HEADER TRANSFERASE 28-SEP-16 5LYH TITLE HUMAN PARP14 (ARTD8), CATALYTIC FRAGMENT IN COMPLEX WITH INHIBITOR H10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PARP-14,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8, COMPND 5 ARTD8,B AGGRESSIVE LYMPHOMA PROTEIN 2; COMPND 6 EC: 2.4.2.30; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: R3 PRARE; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS ADP-RIBOSYLATION, INHIBITOR COMPLEX, TRANSFERASE DOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KARLBERG,A.G.THORSELL,H.SCHULER REVDAT 4 17-JAN-24 5LYH 1 REMARK REVDAT 3 24-JAN-18 5LYH 1 SOURCE REMARK REVDAT 2 11-JAN-17 5LYH 1 JRNL REVDAT 1 21-DEC-16 5LYH 0 JRNL AUTH B.PENG,A.G.THORSELL,T.KARLBERG,H.SCHULER,S.Q.YAO JRNL TITL SMALL MOLECULE MICROARRAY BASED DISCOVERY OF PARP14 JRNL TITL 2 INHIBITORS. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 56 248 2017 JRNL REFN ESSN 1521-3773 JRNL PMID 27918638 JRNL DOI 10.1002/ANIE.201609655 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 24403 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.600 REMARK 3 FREE R VALUE TEST SET COUNT : 2004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.17 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.22 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1711 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 138 REMARK 3 BIN FREE R VALUE : 0.4320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 78 REMARK 3 SOLVENT ATOMS : 19 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -31.74000 REMARK 3 B22 (A**2) : -31.74000 REMARK 3 B33 (A**2) : 63.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.046 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.036 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.116 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.206 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3161 ; 0.015 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 2833 ; 0.006 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4297 ; 1.751 ; 1.948 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6498 ; 1.271 ; 3.007 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 365 ; 7.753 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 168 ;33.279 ;24.226 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 481 ;16.829 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;23.782 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 435 ; 0.100 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3664 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 824 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1466 ; 5.162 ; 5.944 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1465 ; 5.157 ; 5.943 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1826 ; 7.377 ; 8.902 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1827 ; 7.375 ; 8.903 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1692 ; 4.945 ; 6.366 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1693 ; 4.944 ; 6.364 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2469 ; 7.341 ; 9.433 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3404 ;10.628 ;47.368 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3404 ;10.627 ;47.365 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 1613 1801 B 1613 1801 20500 0.10 0.05 REMARK 3 REMARK 3 TWIN DETAILS REMARK 3 NUMBER OF TWIN DOMAINS : 2 REMARK 3 TWIN DOMAIN : 1 REMARK 3 TWIN OPERATOR : H, K, L REMARK 3 TWIN FRACTION : 0.658 REMARK 3 TWIN DOMAIN : 2 REMARK 3 TWIN OPERATOR : -H,-K,L REMARK 3 TWIN FRACTION : 0.342 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5LYH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1200001597. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P13 (MX1) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26408 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 46.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 9.500 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 8.60 REMARK 200 R MERGE FOR SHELL (I) : 1.13000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4F1L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22.5% PEG3350, 0.225M SODIUM MALONATE, REMARK 280 PH 6.8, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.69333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.38667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 81.38667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 40.69333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1609 REMARK 465 MET A 1610 REMARK 465 ASP A 1611 REMARK 465 TYR A 1701 REMARK 465 ALA A 1702 REMARK 465 GLY A 1703 REMARK 465 LYS A 1704 REMARK 465 ASN A 1705 REMARK 465 SER B 1609 REMARK 465 MET B 1610 REMARK 465 ASP B 1611 REMARK 465 MET B 1612 REMARK 465 ALA B 1702 REMARK 465 GLY B 1703 REMARK 465 LYS B 1704 REMARK 465 ASN B 1705 REMARK 465 ALA B 1706 REMARK 465 VAL B 1707 REMARK 465 ALA B 1708 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A1613 145.55 84.51 REMARK 500 ASN A1698 137.75 -3.56 REMARK 500 LYS A1711 72.73 -102.39 REMARK 500 TYR A1727 -65.95 -103.97 REMARK 500 PRO A1793 69.09 -69.87 REMARK 500 GLN B1614 -49.06 81.20 REMARK 500 GLN B1614 -47.64 80.47 REMARK 500 ASN B1698 -168.05 -71.60 REMARK 500 ARG B1699 -105.76 54.93 REMARK 500 LYS B1711 70.46 -102.61 REMARK 500 TYR B1727 -66.03 -104.31 REMARK 500 ASN B1752 -94.89 -130.25 REMARK 500 HIS B1753 -43.58 168.99 REMARK 500 ASN B1776 108.56 -160.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 MET A 1612 LYS A 1613 -136.10 REMARK 500 ARG B 1699 SER B 1700 -30.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7B8 A 1901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7B8 B 1901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5LXP RELATED DB: PDB REMARK 900 5LXP CONTAINS THE SAME PROTEIN COMPLEXED WITH INHIBITOR H5 DBREF 5LYH A 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 DBREF 5LYH B 1611 1801 UNP Q460N5 PAR14_HUMAN 1530 1720 SEQADV 5LYH SER A 1609 UNP Q460N5 EXPRESSION TAG SEQADV 5LYH MET A 1610 UNP Q460N5 EXPRESSION TAG SEQADV 5LYH SER B 1609 UNP Q460N5 EXPRESSION TAG SEQADV 5LYH MET B 1610 UNP Q460N5 EXPRESSION TAG SEQRES 1 A 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 A 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 A 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 A 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 A 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 A 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 A 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 A 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 A 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 A 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 A 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 A 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 A 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 A 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 A 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 193 SER MET ASP MET LYS GLN GLN ASN PHE CYS VAL VAL GLU SEQRES 2 B 193 LEU LEU PRO SER ASP PRO GLU TYR ASN THR VAL ALA SER SEQRES 3 B 193 LYS PHE ASN GLN THR CYS SER HIS PHE ARG ILE GLU LYS SEQRES 4 B 193 ILE GLU ARG ILE GLN ASN PRO ASP LEU TRP ASN SER TYR SEQRES 5 B 193 GLN ALA LYS LYS LYS THR MET ASP ALA LYS ASN GLY GLN SEQRES 6 B 193 THR MET ASN GLU LYS GLN LEU PHE HIS GLY THR ASP ALA SEQRES 7 B 193 GLY SER VAL PRO HIS VAL ASN ARG ASN GLY PHE ASN ARG SEQRES 8 B 193 SER TYR ALA GLY LYS ASN ALA VAL ALA TYR GLY LYS GLY SEQRES 9 B 193 THR TYR PHE ALA VAL ASN ALA ASN TYR SER ALA ASN ASP SEQRES 10 B 193 THR TYR SER ARG PRO ASP ALA ASN GLY ARG LYS HIS VAL SEQRES 11 B 193 TYR TYR VAL ARG VAL LEU THR GLY ILE TYR THR HIS GLY SEQRES 12 B 193 ASN HIS SER LEU ILE VAL PRO PRO SER LYS ASN PRO GLN SEQRES 13 B 193 ASN PRO THR ASP LEU TYR ASP THR VAL THR ASP ASN VAL SEQRES 14 B 193 HIS HIS PRO SER LEU PHE VAL ALA PHE TYR ASP TYR GLN SEQRES 15 B 193 ALA TYR PRO GLU TYR LEU ILE THR PHE ARG LYS HET 7B8 A1901 39 HET 7B8 B1901 39 HETNAM 7B8 3-[2-[4-[2-[[4-[(3-AMINOCARBONYLPHENYL)AMINO]-4- HETNAM 2 7B8 OXIDANYLIDENE-BUTANOYL]AMINO]ETHYL]-1,2,3-TRIAZOL-1- HETNAM 3 7B8 YL]ETHYLSULFAMOYL]BENZOIC ACID FORMUL 3 7B8 2(C24 H27 N7 O7 S) FORMUL 5 HOH *19(H2 O) HELIX 1 AA1 ASP A 1626 SER A 1641 1 16 HELIX 2 AA2 ASN A 1653 GLY A 1672 1 20 HELIX 3 AA3 SER A 1688 GLY A 1696 1 9 HELIX 4 AA4 ASN A 1718 ASN A 1724 1 7 HELIX 5 AA5 ASP B 1626 SER B 1641 1 16 HELIX 6 AA6 ASN B 1653 GLY B 1672 1 20 HELIX 7 AA7 SER B 1688 GLY B 1696 1 9 HELIX 8 AA8 ASN B 1718 ASN B 1724 1 7 SHEET 1 AA1 5 CYS A1618 GLU A1621 0 SHEET 2 AA1 5 ARG A1644 GLN A1652 -1 O ARG A1650 N VAL A1620 SHEET 3 AA1 5 ALA A1791 ARG A1800 -1 O ARG A1800 N ARG A1644 SHEET 4 AA1 5 LYS A1736 LEU A1744 -1 N VAL A1738 O ILE A1797 SHEET 5 AA1 5 GLU A1677 THR A1684 -1 N LEU A1680 O VAL A1741 SHEET 1 AA2 4 THR A1713 ALA A1716 0 SHEET 2 AA2 4 LEU A1782 ALA A1785 -1 O ALA A1785 N THR A1713 SHEET 3 AA2 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 AA2 4 TYR A1748 HIS A1750 1 N THR A1749 O THR A1774 SHEET 1 AA3 5 CYS B1618 GLU B1621 0 SHEET 2 AA3 5 ARG B1644 GLN B1652 -1 O GLN B1652 N CYS B1618 SHEET 3 AA3 5 ALA B1791 ARG B1800 -1 O GLU B1794 N ILE B1651 SHEET 4 AA3 5 LYS B1736 LEU B1744 -1 N VAL B1738 O ILE B1797 SHEET 5 AA3 5 GLU B1677 THR B1684 -1 N LEU B1680 O VAL B1741 SHEET 1 AA4 4 THR B1713 ALA B1716 0 SHEET 2 AA4 4 LEU B1782 ALA B1785 -1 O ALA B1785 N THR B1713 SHEET 3 AA4 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 AA4 4 TYR B1748 THR B1749 1 N THR B1749 O THR B1774 SSBOND 1 CYS A 1618 CYS A 1618 1555 6765 2.19 SSBOND 2 CYS B 1618 CYS B 1618 1555 6765 2.07 SITE 1 AC1 18 HIS A1682 GLY A1683 THR A1684 SER A1688 SITE 2 AC1 18 HIS A1691 PHE A1697 ASN A1698 SER A1700 SITE 3 AC1 18 VAL A1707 GLY A1712 THR A1713 TYR A1714 SITE 4 AC1 18 PHE A1715 ALA A1716 TYR A1721 SER A1722 SITE 5 AC1 18 TYR A1727 ASN B1724 SITE 1 AC2 15 ASN A1724 HOH A2007 HIS B1682 GLY B1683 SITE 2 AC2 15 THR B1684 SER B1688 HIS B1691 VAL B1692 SITE 3 AC2 15 SER B1700 GLY B1712 TYR B1714 TYR B1721 SITE 4 AC2 15 SER B1722 TYR B1727 HOH B2002 CRYST1 83.032 83.032 122.080 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012044 0.006953 0.000000 0.00000 SCALE2 0.000000 0.013907 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008191 0.00000